Ocular Therapeutix (OCUL) Other financing activities (2014 - 2021)
Ocular Therapeutix (OCUL) recorded quarterly Other financing activities of $275000.0 in Q1 2021, up 4483.33% quarter-over-quarter from $6000.0 in Q4 2014.
Ocular Therapeutix (OCUL) Other financing activities (2014 - 2021) Analysis & Trends
Ocular Therapeutix's Other financing activities history runs 2 years deep, the most recent figure standing at $275000.0 for Q1 2021.
- In Q1 2021, Other financing activities changed N/A year-over-year to $275000.0; the TTM figure through Dec 2021 stood at $275000.0 (changed N/A YoY), while the FY2023 annual figure was $5.2 million, changed N/A from the prior year.
- Other financing activities was $275000.0 for Q1 2021 at Ocular Therapeutix, up from $6000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $275000.0 in Q1 2021 to a low of $275000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 275,000.00 |
| Mar 31, 2021 | 275,000.00 |
| Dec 31, 2014 | 6,000.00 |
| Dec 31, 2014 | 6,000.00 |
| Sep 30, 2014 | 1.91 Mn |
| Sep 30, 2014 | 1.91 Mn |